Proton beam therapy in pediatric oncology

Area of Science:

• Pediatric Radiation Oncology
• Medical Physics
• Cancer Treatment

Background:

• Proton beam therapy (PBT) represents a significant advancement in pediatric radiation oncology.
• There is a growing number of PBT centers in the United States.
• Evidence supporting PBT's efficacy in pediatric cancers requires critical evaluation.

Purpose of the Study:

• To review the quality of evidence for PBT in pediatric cancers.
• To discuss the benefits and risks of PBT in this patient population.

Main Methods:

• Review of existing literature on PBT for pediatric cancers.
• Analysis of data on toxicity, quality of life, and disease outcomes.

Main Results:

• PBT demonstrates potential for decreased incidence and severity of late effects, especially in pediatric brain tumors, improving neurocognitive, hearing, and endocrine outcomes.
• Modified dose recommendations for brainstem toxicity with PBT have been established.
• Reduced toxicity has also been observed in non-central nervous system pediatric tumors, including sarcomas, Hodgkin disease, and neuroblastoma.
• Improved quality of life (QoL) outcomes are reported for pediatric patients treated with PBT.

Conclusions:

• Findings indicate an enhanced understanding and refinement of PBT applications in pediatric cancers.
• Continued data collection on QoL, toxicity, and disease outcomes is crucial for a comprehensive assessment of PBT's risks and benefits.